publicações selecionadas artigo de revista 3-Bromopyruvate Suppresses the Malignant Phenotype of Vemurafenib-Resistant Melanoma Cells. International Journal of Molecular Sciences. 2022 documento Metabolic characterization and 3-bromopyruvate sensitivity screening in 12 melanoma cell lines. 2018